ACHIEVE LIFE SCIENCES, INC.
Data quality: 83%
ACHV
Nasdaq
Manufacturing
Chemicals
$3.28
▲
$0.02
(0.61%)
Mkt Cap: 174.63 M
Price
$3.28
Mkt Cap
174.63 M
Day Range
$3.20 — $3.30
52-Week Range
$1.95 — $6.03
Volume
230,373
Open $3.21
50D / 200D Avg
$4.09
19.79% below
50D / 200D Avg
$3.81
13.81% below
Quick Summary
Key Takeaways
Negative free cash flow of -49.47 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-145.18%
Below sector avg (-51.02%)
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio5.14
Interest CoverageN/A
Valuation
PE (TTM)
-3.20
Below sector avg (-1.98)
P/B Ratio5.19
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.2 | -2.0 |
| P/B | 5.2 | 5.1 |
| ROE % | -145.2 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
ETFs Holding This Stock
5.40% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -54.65 M |
| ROE | -145.18% | ROA | -98.49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -49.47 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 5.14 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 40.33 M | Tangible Book Value | 31.77 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3.20 | Forward P/E | N/A |
| P/B Ratio | 5.19 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -28.33% | ||
| Market Cap | 174.63 M | Enterprise Value | 142.70 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.25 | Revenue / Share | N/A |
| FCF / Share | -0.93 | OCF / Share | -0.93 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 90.52% |
| SBC-Adj. FCF | -58.27 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -54.65 M | -39.83 M | -29.82 M | -42.35 M | -33.15 M |
| EPS (Diluted) | -1.25 | -1.24 | -1.50 | -4.00 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | 22.82 M | 15.81 M | 30.08 M | 23.97 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 228,000.0 | 229,000.0 | 228,000.0 | 236,000.0 | — |
| Interest Expense | 819,000.0 | 2.18 M | 2.85 M | 1.79 M | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 41.79 M | 38.63 M | 19.37 M | 29.97 M | 47.52 M |
| Total Liabilities | 20.27 M | 17.73 M | 20.82 M | 21.67 M | 19.47 M |
| Shareholders' Equity | 21.52 M | 20.90 M | -1.45 M | 8.30 M | 28.04 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 20.93 M | 12.75 M | 15.55 M | 24.77 M | 43.02 M |
| Current Assets | 39.89 M | 36.47 M | 16.98 M | 27.33 M | 44.59 M |
| Current Liabilities | 9.08 M | 6.68 M | 20.81 M | 21.60 M | 4.55 M |
{"event":"ticker_viewed","properties":{"ticker":"ACHV","listing_kind":"stock","pathname":"/stocks/achv","exchange":"Nasdaq","country":"US"}}